BEST Penny Stocks to Watch
Here is a group of low price penny stocks that have something special. That could include game changing technology or insider buying.
Best Low Price Stocks To WATCH
We are constantly scanning for low price companies that either have game changing technology OR may have unusually large amount of insider buying. These are companies that are typically nanocaps (under $100M mkt cap), trade on the lower exchanges, and dont have coverage.
Here are some ones that we found of interest.
These are considered HIGHLY SPECULATIVE companies. THIS IS NOT FINANCIAL ADVICE.
Companies that are highlighted in BLUE are clients.
Disclaimer: The information provided regarding stocks is for informational and educational purposes only and should not be construed as financial advice or a recommendation to buy, sell, or hold any securities. We are not financial advisors, and the content does not account for your individual financial situation or investment goals. Investing in stocks involves risks, and you should consult a qualified financial professional and conduct your own research before making any investment decisions. We assume no liability for any losses or damages arising from the use of this information.
Penny Stocks We Are Watching
ALUR Allurion Technologies
AMFN American Fusion
AMIX Autonomix Medical
BESS Bimergen Energy
CHUC Charlie’s Holdings
CEIN Camber Energy
FABC Fabric.AI
FEMY Femasys
HPNN Hop On Inc
HYLN Hyliion Holdings
IDAI T Stamp Inc
INBS Intelligent Bio Solutions
IPST IP Strategy
IPWR Ideal Power
LEXX Lexaria Biosciences
LIXT Lixte Biotechnology
MBAI MBody AI
MYVA Metavia
NSPR InspireMD
PMEDF QScreen AI
PRSO Peraso Inc
QTI QT Imaging Holdings
RBOT Vicarious Surgical
SMTK SmartKem Inc
SPAIF Sparc AI Inc
TELIF Telescope Innovations
VANI Vivani Medical
VNRX VolitionRX Limited
ALUR Allurion Technologies
ALUR helps people lose weight using a swallowable medical balloon instead of surgery.
Allurion Technologies is a medical technology company focused on non-surgical weight loss solutions. Its flagship gastric balloon system is swallowed like a capsule and works alongside digital health coaching and software monitoring.
The company is positioned within the expanding global obesity and metabolic health market.
AMFN American Fusion
Their Texatron™ aneutronic fusion could LEAPFROG nuclear power
AMFN is developing fusion energy technology designed to produce massive amounts of clean power for AI infrastructure, defense, and future energy grids.
American Fusion is an advanced energy company focused on developing aneutronic fusion technology through its Texatron™ platform.
The company is positioning itself around the growing global demand for high-density power driven by AI data centers, defense systems, and next-generation infrastructure. AMFN has recently highlighted government engagement, defense procurement activity, SEC reporting milestones, and strategic supply chain discussions tied to fusion fuel development.
Investors are watching AMFN as a speculative fusion energy play connected to the long-term future of power generation and AI infrastructure demand.
AMIX Autonomix Medical
Autonomix has developed a breakthrough nerve-sensing technology that acts like a GPS for the nervous system, helping physicians locate and target specific nerves with unprecedented precision.
The platform has the potential to transform pain management and minimally invasive procedures across multiple billion-dollar healthcare markets.
Creating a GPS-like navigation system for the human nervous system that could revolutionize precision medicine.
BESS Bimergen Energy
BESS is trying to become the battery-storage equivalent of a power plant developer.
Bimergen is developing utility-scale battery energy storage systems (BESS). These giant battery installations store electricity when power is abundant and cheap, then discharge it when demand and prices are higher. The batteries help stabilize the grid and support renewable energy sources like wind and solar.
Imagine if cars had nowhere to park and had to keep driving around all day. Parking garages would become incredibly valuable. Battery storage does the same thing for electricity. It gives power a place to “park” until it’s needed.
Bimergen’s bet is that owning thousands of megawatt-hours of parking space for electricity will become one of the most valuable pieces of the future energy grid.
The market is valuing Bimergen as a tiny company today, but if it successfully develops even a portion of its multi-gigawatt battery pipeline, it could become a meaningful owner of energy infrastructure.
CEIN Camber Energy
CEIN is trying to modernizing the grid: Broken Conductor Protection (BCPT)
Camber’s primary contribution to grid modernization is its patented Broken Conductor Protection Technology.
CHUC Charlie’s Holdings
MULTIPLE CLUSTER INSIDER BUYING
CHUC owns avery large flavored vape PMTA portfolio (imputed value over $650M) that could become highly valuable now that the FDA approved flavored vape PMTAs.
The company has become increasingly watched due to its portfolio of FDA-filed flavored vape PMTAs
Here is how the FDA Decision could impact CHUC
Big Tobacco has quietly started to acquire CHUC PMTAs
The company has also reported strong recent revenue growth and profitability improvements while pursuing potential exchange uplisting plans.
FABC Fabric.AI
Fabric.AI is positioning itself as an AI infrastructure company focused on solving one of the biggest hidden problems in artificial intelligence. How AI systems move massive amounts of data between chips, servers, and devices fast enough to keep up with next-generation AI workloads.
The company is developing Neural I/o™, a MicroLED-based optical interconnect chip jointly developed with Kopin Corporation.
The company is not trying to compete directly against GPU makers. Instead, they want to build enabling technologies that make massive AI systems more efficient.
The interesting angle is that interconnect technology could become one of the most critical layers of AI infrastructure over the next decade.
FEMY Femasys
Femasys has two potentially disruptive women’s health technologies. .
FemaSeed is an advanced fertility treatment designed to deliver sperm directly into the fallopian tube, the natural site of conception, potentially improving fertilization rates while offering a far lower cost and lower risk alternative to IVF or ICSI. The technology is already approved across major markets including the U.S., Europe, U.K., Canada, and Israel.
FemBloc is a first-of-its-kind non-surgical permanent birth control procedure that uses a proprietary biodegradable polymer to create scar tissue that permanently blocks the fallopian tubes, eliminating the need for surgical sterilization. Unlike older approaches, it avoids implanted metal devices and is designed as a lower-cost in-office procedure with fewer risks and recovery issues.
The biggest issue facing the stock is that despite the compelling technology and large market opportunity, commercial adoption and revenue growth remain limited so far, causing investors to question whether the company can successfully scale physician usage, reimbursement, and patient demand before needing additional financing.
HPNN Hop On Inc
Digitalage is building what could become the operating system for digital ownership, combining content licensing, creator compensation, and verified digital delivery into a single platform.
If successful, it could transform how intellectual property is bought, sold, and monetized across the internet.
Building the infrastructure for a future where digital assets, content rights, and creator payments flow seamlessly across the internet.
HYLN Hyliion Holdings
Hyliion Holdings Corp. basically proved it can build a power generator that can run on almost any major fuel, without needing to swap parts or redesign the machine.
Think of it like a car that could instantly switch between gasoline, diesel, hydrogen, and natural gas while driving, without stopping at a mechanic or changing the engine. That’s what makes this important.
In simple terms, Hyliion is trying to build the “universal charger” of power generators.
IDAI T Stamp Inc
IDAI uses artificial intelligence to verify identities and stop fraud before it happens.
T Stamp develops AI-powered biometric identity solutions for governments, banks, fintech companies, and security systems.
Its technology analyzes facial biometrics and trust-based AI models to help verify users while reducing fraud risks. Investors see IDAI as an emerging player in the growing AI cybersecurity and digital identity market.
INBS Intelligent Bio Solutions
Intelligent Bio Solutions is disrupting drug and alcohol testing with a rapid, non-invasive fingerprint-based screening technology that could replace traditional urine and saliva testing.
The platform addresses a massive global workplace safety market seeking faster, easier, and more reliable compliance solutions.
Transforming workplace drug testing with a simple fingerprint scan that delivers rapid, non-invasive results.
IPST IP Strategy
IP Strategy Holdings, Inc. is basically betting that AI will need a secure way to use and pay for valuable data, ideas, and content, and they own part of the blockchain infrastructure trying to power that future.
They’re building a blockchain-powered system that helps companies safely own, license, and make money from data and intellectual property used by AI.
Confidential Data Rails (CDR) initiative strengthens this thesis by enabling AI systems to securely use sensitive private data without exposing or transferring the underlying information. This could unlock monetization opportunities
IPWR Ideal Power
INSIDER BUYING
IPWR develops technology that reduces wasted electricity and heat in high-power electronic systems.
Ideal Power is a semiconductor technology company behind B-TRAN™, a patented power switch designed to improve efficiency in electric vehicles, renewable energy systems, AI data centers, and industrial power infrastructure.
The company’s technology aims to reduce friction from electricity flow, potentially lowering energy loss and cooling costs. Bulls believe a major licensing or manufacturing partnership could significantly expand adoption.
LEXX Lexaria Biosciences
LEXX is developing technology designed to help drugs absorb into the body faster and more efficiently.
Lexaria Bioscience is a biotechnology company focused on its patented DehydraTECH™ drug delivery platform, which improves how active ingredients enter the bloodstream. The company is targeting major markets including GLP-1 obesity drugs, nicotine, cannabinoids, and pharmaceutical delivery. Investors are watching LEXX because its technology could potentially improve oral drug performance without creating entirely new drugs.
Bulls see it as a licensing/IP play tied to the exploding obesity-drug market.
LIXT Lixte Biotechnology
LIXT is developing drugs designed to stop cancer cells from repairing themselves, making chemotherapy and immunotherapy work harder.
The company is essentially trying to “turn off cancer’s survival switch.”
Cancer cells normally use repair mechanisms to recover after being damaged by treatment. LIXT’s approach attempts to block that recovery process, forcing damaged cancer cells to continue dividing until they die
If the science works, treatments that already exist may suddenly become much more powerful against resistant cancers
MBAI MBody AI
MBody AI is an embodied artificial intelligence company building the autonomous workforce of the future.
Its proprietary, hardware-agnostic MBody AI Orchestrator™ platform delivers real-time data intelligence and AI-driven performance insights for robotic fleets, with capabilities spanning deployment optimization, predictive maintenance, and full-fleet coordination.
MBody AI serves Fortune 500 enterprises and blue-chip customers across multiple industry verticals.
MTVA Metavia Inc
Metavia is designing A next-generation obesity drug designed to help people lose more fat by both reducing appetite and increasing calorie burning, while potentially preserving more muscle and causing fewer side effects than current GLP-1 drugs like Wegovy or Zepbound.
What makes DA-1726 especially interesting is that early data suggests patients may lose similar or greater weight while eating more food compared to some competing drugs. That hints at a more efficient metabolism instead of simply “starving the patient thinner.”
MetaVia is positioning DA-1726 as a possible “best-in-class” obesity and metabolic therapy rather than just another GLP-1 copycat.
NSPR InspireMD
CLUSTER INSIDER BUYING
InspireMD is trying to solve one of the biggest problems in carotid artery stenting, preventing strokes caused by debris breaking loose after a stent is implanted.
The key innovation is the patented “MicroNet” mesh layer. Instead of relying only on metal struts like older stents, CGuard adds an ultra-fine PET mesh covering with pore sizes around 150 to 180 microns. That mesh acts like a filter that traps plaque and blood clot material against the artery wall before it can travel to the brain.
InspireMD is not just selling another stent. They are trying to create what they believe could become the next-generation standard for carotid artery intervention.
PMEDF QScreen AI
PMEDF uses AI-powered screening technology to detect health risks, impairment, and potential illness before problems become visible
QScreen AI is a healthcare technology company developing artificial intelligence systems for workplace safety, health screening, and early detection monitoring.
Formerly known as Predictmedix AI, the company focuses on AI-powered scanning stations capable of identifying impairment, infectious illness symptoms, fatigue, and mental health indicators using facial analysis and behavioral data
Investors are watching PMEDF because it sits at the intersection of AI, health surveillance, workplace safety, and preventative healthcare technology
PRSO Peraso Inc
They are building a unique wireless network.
PRSO develops ultra-fast wireless technology designed for next-generation communications.
Peraso develops mmWave wireless chips and semiconductor solutions for high-speed internet, military communications, fixed wireless access, and advanced networking systems.
The company’s technology is designed to move large amounts of data quickly with low latency. Investors are watching PRSO due to growing demand for AI infrastructure and defense communications technology
QTI QT Imaging Holdings
QTI is targeting one of the biggest problems in breast cancer screening: dense breast tissue. About 40% of women have dense breasts, which can make cancers harder to detect on mammograms because both dense tissue and tumors appear white on the scan.
In preliminary Mayo Clinic comparisons, QT’s imaging reportedly detected all findings identified by MRI, while also potentially reducing unnecessary biopsies by improving tissue characterization.
They have proprietary “speed-of-sound” imaging technology.
QTI recently secured a Category III CPT reimbursement code that becomes effective January 1, 2027, which is viewed as the first major step toward future insurance coverage.
RBOT Vicarious Surgical
Funded by Bill Gates and Vinod Khosla’s Ventures.
The Vicarious Surgical robot design intends to maximize visualization, precision, and control of instruments in robotic-assisted minimally invasive surgery.
It’s almost as if the surgeon is transported into the patient’s body.
SMTK SmartKem Inc
SmartKem is developing next-generation semiconductor materials that could change how wearable devices are built. The company recently signed a paid proof-of-concept deal with a global electronics company to create ultra-small curved smart wearables using its proprietary organic thin-film transistor (OTFT) technology combined with MicroLED displays.
Its technology is designed to solve major wearable challenges like lower battery use, brighter outdoor screens, durability, and extreme miniaturization.
SmartKem also developed what it says is the world’s first all-organic transistor biometric sensor, which could improve fingerprint and palm recognition on curved devices while helping detect fake fingerprints through advanced liveness detection.
SPAIF Sparc AI Inc
The company is positioning itself as an AI software backbone for autonomous systems operating where GPS no longer works.
Unlike competitors that require expensive hardware upgrades or specialized manufacturing, SPARC AI operates entirely through software. That means faster deployment, lower costs, easier scalability, and potentially very high profit margins. Management states the business model can achieve gross margins above 95%, while also generating recurring software revenue.
The company’s broader vision appears to be creating a geospatial intelligence layer across autonomous systems of all types:
- Military drones
- Unmanned ground vehicles
- Maritime systems
- Robotics platforms
- Autonomous defense technologies
TELIF Telescope Innovations
Telescope Innovations is pioneering the development and deployment of “self-driving labs” (SDLs). By integrating proprietary automation hardware with advanced machine learning,
Telescope creates closed-loop, physical AI systems that autonomously discover and optimize new molecules.
This technology is already validated and generating revenue through strategic, partnerships by accelerating pharmaceutical development pipelines with Pfizer, optimizing critical battery material extraction with Standard Lithium, and scaling commercial hardware distribution through a global alliance with Mettler-Toledo.
VANI Vivani Medical
HEAVY INSIDER BUYING
VANI develops tiny implants that can slowly release medicine into the body for months or years.
Vivani Medical is a biotech and medical device company creating long-duration drug implants for obesity, diabetes, and chronic diseases. Its technology is designed to deliver therapies continuously over extended periods, potentially improving patient convenience and compliance.
Investors are particularly focused on its obesity treatment pipeline tied to GLP-1 drugs
VNRX VolitionRX Limited
VNRX is developing blood tests designed to detect cancer earlier and more easily.
VolitionRx is a diagnostics company developing blood-based cancer detection tests using nucleosome science. Its technology aims to identify cancer and other diseases through less invasive testing methods for both humans and animals.
Investors are interested in VNRX because early cancer detection remains one of the largest opportunities in healthcare diagnostics.
Real Creative Agency
Digital Marketing Experts
Daily helping our most valuable asset “YOU” since 2005.
